News

Nomura Research Institute Stock Update: Downgrade Yet Positive Projections

Nomura Research Institute Stock Update: Downgrade Yet Positive Projections

Latest Developments in Nomura Research Institute Stock

Recently, the financial community has been observing the stock performance of Nomura Research Institute Ltd. (OTC: NRILY). On a notable Friday, Jefferies made a significant update by downgrading the company's stock from Buy to Hold, concurrently raising the price target to ¥5,500 from ¥5,120. This reflects a price-to-earnings (P/E) ratio of 32.2 times, projected from an anticipated earnings per share (EPS) of ¥170.8 for the fiscal year concluding in March 2026.

Understanding the Shift: Downgrade Logic

While the elevation of the price target suggests optimism, the downgrade to Hold indicates that Nomura's stock is currently in a precarious position. Trading within the 30x P/E range, the company lacks immediate catalysts to spark significant price appreciation. Jefferies concluded that the potential upside compared to current valuations is limited, leading to their cautious stance.

Positive Prospects for International Operations

Jefferies forecasts a turnaround for Nomura's US business and international operations, projecting profitability starting from the third quarter. This optimism stems from ongoing restructuring efforts, which may lead to a positive revision of earnings guidance for the fiscal year ending March 2025. However, market reactions might be muted, as the market has likely factored upcoming quarterly performances into current valuations.

Domestic Strengths and Market Recognition

Nomura Research Institute continues to thrive in its local market, particularly with its successful Consulting division, which has shown resilience. Additionally, being included in major index listings is simplifying factors in its stock price uplift. The market seems to recognize the firm’s robust fundamentals and its potential to recover overseas, aligning with how its stock is perceived currently.

Recent Analyst Activity and Market Reactions

In the wake of Jefferies' update, other institutions have also weighed in on Nomura Research Institute’s stock. Macquarie altered its outlook, adjusting its rating from Outperform to Neutral, while Morgan Stanley shifted from Overweight to Equalweight. Interestingly, both firms increased their price targets; Macquarie to ¥4,500 and Morgan Stanley to ¥5,200, anticipating a healthy fiscal year 2025 operating profit of ¥137.5 billion, signaling a projected 14% year-over-year growth.

Financial Insights and Future Expectations

Morgan Stanley's analysis hints at an anticipated improvement in gross profit margin to 36.1%, up 0.7 percentage points. Their projections also indicate a 12% rise in operating profit domestically, alongside significant growth overseas.

Additional Insights on Nomura Research Institute

Recent findings add more perspective to Jefferies' evaluation of Nomura Research Institute Ltd. (OTC: NRILY). Their market capitalization stands at an impressive $20.03 billion, with a P/E ratio of 35.51 that indicates a relatively high valuation, corroborating Jefferies’ observations. The firm’s revenue recently reported was $4.65 billion over the past year, with growth recorded at 6.65%, solidifying positive forecasts directed at the domestic operations.

Stable Dividend Payments Indicate Robust Health

Highlighting Nomura's financial stability is the fact that it has maintained consistent dividend payments for 23 consecutive years. This record showcases the company's commitment to returning value to shareholders while reinforcing its place in the market.

Recent Stock Performance Dynamics

Aligning with the positive trends noted, data showcases a remarkable 31.39% total price return for Nomura over the past six months, reaching 91.17% of its 52-week peak. These figures point toward a resilient stock position amid the adjustments made by analysts.

Frequently Asked Questions

What was the recent rating change for Nomura Research Institute?

Jefferies downgraded the stock from Buy to Hold while raising its price target to ¥5,500.

What are the projected earnings for Nomura Research Institute?

The estimated earnings per share (EPS) for the fiscal year ending March 2026 is ¥170.8.

Why did Jefferies downgrade Nomura Research Institute?

The downgrade reflects a lack of immediate catalysts and limited potential for stock price appreciation.

What are the expectations for Nomura's international operations?

Analysts expect profitability starting from the third quarter due to restructuring efforts.

How has Nomura Research Institute performed recently?

Nomura has shown a 31.39% return over the past six months, indicating robust market activity.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sinopec Unveils Biodiversity Report at COP17

Updated Category News Views 47

Sinopec's First Step on the Global Biodiversity Stage Seems like Sinopec (HKG: 0386) has decided to toss its hat into the biodiversity conservation ring. At COP17 in Armenia, they released their inaugural Global Biodiversity Conservation Report—an event that marks more than just a company selling oil and gas. Now, they're talking wildlife and ecologies. Is that irony,...

Continue Reading
Veteran Surge in 2026 Midterm Elections: A New Wave

Updated Category News Views 43

A Swell of Veteran Candidates Hits the Midterm Shores Just when you think you've seen it all in politics, here comes another twist. As the 2026 midterms gear up, an impressive 258 military veterans are throwing their hats into the congressional ring. That's a jump up from 213 just two years back, and let me tell you, it's not just a numbers game—it's a sea change. Women...

Continue Reading
HIZENERGY Sustains Tier 1 Status Amid Tighter Criteria

Updated Category News Views 90

Another Feather in HIZENERGY's Cap In a landscape where credibility can make or break a business, HIZENERGY has once again staked its claim as a powerhouse. Come Q4 2026, and despite a rougher sea to navigate with BloombergNEF’s (BNEF) upgraded Tier 1 criteria, the company held its own. For those unacquainted, securing a place on this lofty list involves some serious...

Continue Reading
New Era Celebrates Valkyries' Groundbreaking WNBA Win

Updated Category News Views 217

A Surprising Win for a Rising Team In the world of sports, sometimes the odds are defied, and stories of triumph unfold that capture the imagination. The Golden State Valkyries did exactly that by snagging their first WNBA Championship title just a year after entering the league. It's a narrative right out of a Hollywood script—only this time, it's inked in real...

Continue Reading
ENGWE Unleashes Massive Black Friday E-Bike Discounts

Updated Category News Views 70

ENGWE Powers Up the 2026 Black Friday Storm If you’ve ever been on the hunt for a reliable e-bike, ENGWE is making a racket that’ll be impossible to ignore this Black Friday. Starting November 2nd and running up to December 3rd, they’re throwing down the gauntlet with some jaw-dropping deals across their line-up. Now, why should you care? For starters, they’ve...

Continue Reading
Cleafy's Cyber-Fraud Edge in SPARK Matrix™ 2026

Updated Category News Views 0

What's Cookin'? Cleafy Leads in Fraud Management Lineup Eying the world through a prism of calculated risk and opportunity, Cleafy has emerged a big dog in the latest QKS Group SPARK Matrix™ for Enterprise Fraud Management, 2026. The spotlight's on their cutting-edge knack for dodging cyber fraud's punches, a distinction that hints at a deeper market shift for those who...

Continue Reading
Perion Acquisition: Affle's Bold Leap in Ad Tech

Updated Category News Views 228

Affle's Strategic Acquisition of Perion Jumpin' through another hoop, Affle is gearing up to snag Perion in a hefty deal valued at about $420 million. For those of you not knee-deep in the ad tech sandbox, Affle—trading on the NSE as AFFLE—is aiming to ramp up its AI-driven conversion game by absorbing Perion, a veteran in the omnichannel advertising realm. "This...

Continue Reading
Isinwheel's 2027 E-Mobility Pitch: Beyond Resolutions

Updated Category News Views 163

Embracing the E-Mobility Shift Here we are at the tail end of 2026, and isinwheel is riding high on the wave of New Year resolutions with their hefty e-mobility lineup. It's not just about buying the gear—it's about tackling our reliance on gas-guzzlers with electric scooters and bikes as our trusty steeds. "Reduce car trips? More greenery in your commute? These aren't...

Continue Reading
Stellantis Harnesses AI for Customer Connection Boost

Updated Category News Views 0

Trading Mayhem: Pre-Market Vibes Ever put your ear to the ground on the NYSE floor and felt that buzz of untamed optimism clashing with skepticism? Today it's all about connections, from the data-driven to the familial. Imagine Stellantis (NYSE: STLA) is making a play, aligning with Amperity in an ambitious attempt to make customer interactions feel more personal. Now,...

Continue Reading
RD Technologies Ramps Up Cross-Border Payments

Updated Category News Views 160

RD Technologies: Revving Up the Payment Game RD Technologies is at it again, jazzing up its game in the cross-border payments realm. One can almost smell the digits doing a tango across continents—particularly as Hong Kong's financial warriors set their sights on beefing up trade between Africa and Asia. New Alliances in the Payment Arena Here's a roadmap: Connect the...

Continue Reading

Top 5 Most Recently Viewed Articles

Rural Healthcare Transformation: Data-Driven Innovations in Practice

Updated Category News Views 234

Revolutionizing Rural Healthcare with Data-Driven Solutions REDi Health Analytics, LLC ("REDi Health") has forged a partnership with a state health department to significantly boost the data capacity of six rural hospitals. Their goal is to enhance healthcare delivery and bridge the health disparities prevalent in rural communities. As highlighted by John Wadsworth,...

Continue Reading
Boeing Charges Union with Unfair Labor Practices Amid Strikes

Updated Category News Views 194

Boeing Takes Action Against Striking Union Boeing, a leading name in aerospace manufacturing, has recently initiated a charge of unfair labor practices against the union representing approximately 33,000 West Coast factory workers. This action highlights the ongoing tensions amid the strike that has disrupted operations. Allegations of Bad Faith Bargaining The charge was...

Continue Reading
Deckers Outdoor Adjusts to Split with New Price Target Set

Updated Category News Views 58

Deckers Outdoor Stock Price Target Update Recently, Evercore ISI made headlines by revising its price target for the shares of Deckers Outdoor (NYSE: DECK), adjusting it down to $183 from the previous level of $1,100. This reduction, while significant, comes after the company undertook a 6-for-1 stock split, a move aimed at making the stock more appealing to investors....

Continue Reading
Beam Therapeutics Welcomes Sravan Emany as New CFO

Updated Category News Views 247

Beam Therapeutics Welcomes a New Chief Financial Officer Beam Therapeutics Inc. (Nasdaq: BEAM), a leader in developing precision genetic medicines, is heralding an important new chapter in its journey with the appointment of Sravan K. Emany as its Chief Financial Officer (CFO). Bringing vast experience from his previous roles in well-established corporations, Mr. Emany is...

Continue Reading
Keysight Technologies Partners with UL Solutions for Certification

Updated Category News Views 192

Keysight Technologies, Inc. (NYSE: KEYS) made headlines by securing its role as a test partner for Thunderbolt 5 certification back in 2024. This partnership with UL Solutions is no small feat—it's a strategic play that puts Keysight squarely in the fast lane of advanced connectivity. As the landscape shifts, this collaboration hints at what’s coming: faster speeds...

Continue Reading